New Facilities to Drive Production Sales of Food Encapsulation

Food Encapsulation Market

Increasing urban population is expected to drive the demand for functional foods, which in turn is expected to fuel the need for food encapsulation. Apart from this, rising need for preservation of active and core materials, need for innovative product appeal amongst the consumers has further contributed towards the expansion of global market for food encapsulation. However, shifting consumer needs and growing preference for fortified foods are some factors that are hindering the growth of global market for food encapsulation.

A recent report anticipates that the global market for food encapsulation will expand at a healthy 9.4% CAGR during the forecast period, 2015-2020, to touch an evaluation of nearly US$ 5,464.6Mn by the end of 2020. Companies namely Koninklijke DSMN.V. (ADR), Appvion, Inc., International Flavors & Fragrances Inc., Givaudan SAADR, Firmenich International SA, Symrise AG, Balchem Corporation and Taste Tech Ltd., amongst others will observe a substantial growth worldwide. Leading companies are concentrating on marketing strategies such as product developments and expanding their product portfolio. Apart from this, companies such as AnaBio Technologies Ltd. are also contributing significantly towards the expansion of global market for food capsulation.

AnaBio Technologies Ltd. Opens New Facility in Ireland

AnaBio Technologies Ltd. specializes in encapsulation utilizing natural food proteins. The company has core technologies for commercializing and developing natural food-grade mini-encapsulation, which are patented to target, protect and stabilize sensitive ingredients. The applications are inclusive of antibiotics, vaccines, enzymes, omega oils, nutraceutical, sports supplements and probiotics.

AnaBio opens new facility near Cork, in Carrigtwohill, Ireland. The company is looking forward to more collaborations for the expansion of business. Recently, six clinical tests was conducted on one of its produces, with regards to weight management and glucose regulation. Also, the company is all set to reveal it’s another trademarked product, which is dependent on scientific evidence for supporting the company’s encapsulation process. This is done considering the crucial effects on post-prandial blood glucose stages.

Apart from this, the product also controls post-prandial blood glucose stages that have directed substantial rise in the insulin sensitivity for “at risk” and “normal” populace. AnaBio Technologies Ltd. continues to work on the potential for usage of encapsulation, in order to deliver insulin orally along with Professor David Brayden as well as his team in the University College, Dublin. Irish government agencies have insisted the company to make progress with regards to encapsulation in Ireland. Within the immediate 12 months, AnaBio Technologies Ltd. is expected to significantly increase its production line.

AnaBio Technologies Ltd. has come up with new product line of its trademarked brand-probiotics. The company has its own standard probiotic strains, which they plan to encapsulate and are acid as well as heat stable against UHT and pasteurization. Furthermore, AnaBio Technologies Ltd. will be developing its portfolio of ingredients, which are appropriate for encapsulation. The encapsulation process will be done in case of nutraceutical, oil as well as probiotics. Manufacturers can look forward to the company’s 12 patents, which are completely commercialized.

The company delivered its probiotics to American market, centering to cats and dogs. The new facility enables AnaBio Technologies Ltd. to conduct all the required research and development process along with production.

A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-380

Be the first to comment

Leave a Reply

Your email address will not be published.


*